medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2009, Number 12

<< Back

Ginecol Obstet Mex 2009; 77 (12)

Clinical practice guides 2008. Mexican College of Specialists in Gynecology and Obstetrics. Mastalgia treatment

Mainero RFE, Aguilar GUI

Language: Spanish
References: 55
Page: 371-390
PDF size: 652.84 Kb.


ABSTRACT

No abstract


REFERENCES

  1. Rosolowich V, Saetller E, Szuck B. Mastalgia. J Obstet Gynaecol Can 2006;28:49-60.

  2. Olawaiye A, Withiam-Leitch M, Oanakas G, Kahn K. Mastalgia: a review of management. J Reprod Med 2005;50(12):933-9.

  3. Ader ON, South-Paul J, Adera T Deuster PA. Cyclical mastalgia: prevalence and associated health and behavioral factors. J Psychosom Obstet Gynaecol 2001; 22:71-6.

  4. Preece PE, Mansel RE, Bolton PM, Hughes LE, Baum M, Gravelle IH. Clinical syndromes of mastalgia. Lancet 1976;02:670-3.

  5. Rea N, Bove F, Gentile A, Parmeggiani U. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment. Minerva Med 1997; 88: 479-87.

  6. Goodwin PJ, Miller A, Del Guidice ME, Singer W, Connelly P, Knox, et al. Elevated high-density lipoprotein, cholesterol and dietary fat intake in women with cyclic mastalgia. Am J Obstet Gynecol1998;179:430-7.

  7. Peter F, Diemer P. Mecks O, Behnken LJ. Severity of mastalgia in relation to milk duct dilatation. Obstet GynecoI 2003;101:54-60.

  8. Cochrane RA, Singhal H, Monypenny IJ, Webster DJT, Lyons K, Mantel RE. Evaluation of general practitioner referrals to a specialist breast clinic according to the UK national guidelines. Eur J Surg Oncol1997;23:198-201.

  9. Plu-Bureau G, Le MG, Sitruk-Ware R, Thalabard JC. Cyclical mastalgia and breast cancer risk: results of a French cohort study. Cancer Epidemiol Biomarkers Prev 2006 Jun;15(6):1229-31.

  10. Downey HM, Deadman JM, Davis C, Leinster SJ. Psychologic characteristics of women with cyclical mastalgia. Breast Dis 1993;6:99-105.

  11. Ramirez AJ, Jarrett SR, Hamed H, Smith P, Fentiman IS. Psychosocial adjustment of women with mastalgia. Breast 1995;4:48-51.

  12. Barros AC, Mottola J, Ruiz CA, Borges MN, Pinotti JA. Reassurance in the treatment of mastalgia. Breast J 1999;5:62-5.

  13. Fox H, Walker LG, Heys SO, Ah-See AK, Eremin O. Are patients with mastalgia anxious, or does relaxation therapy help? Breast 1997;6:138-42.

  14. Wilson MC, Sellwood RA. Therapeutic value of a supporting brassiere in mastodynia. Br Med J 1976;6027:90.

  15. Hadi MS. Sports brassiere: is it a solution for mastalgia? Breast J 2000;6:407-9.

  16. Colacurci N, Mele O, De Franciscis P, Costa V, Fortunato N, De Seta L. Effects of tibolone on the breast. Eur J Obstet Gynecol Reprod Biol 1998;80:235-8.

  17. Lopes P, Merkus H, Nauman J, Bruschi F, Foidart J, Calaf J. Randomized comparison of intranasal and transdermal estradiol. Obstet Gynecol 2000;96:906-12.

  18. Mattsson, LA, Christiansen C, Colau J, Palacios S, et al. Clinical equivalence of intranasal and oral 17b-estradiol for postmenopausal symptoms. Am J Obstet Gynecol 2000;182:545-52.

  19. Klimberg VS. Etiology and management of breast pain. In: Bland KI, Copeland EM, eds. The Breast. Comprehensive management of benign and malignant diseases. 2nd ed. Philadelphia: WB Saunders;1998;pp:2-55.

  20. Audet M, Moreau M, Koltun WD, Waldbaum AS, et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive. JAMA 2001;285:2347-54.

  21. Euhus DM, Uyehara C. Influence of parental progesterones on the prevalence and severity of mastalgia in pre-menopausal women: a multi-institutional cross-sectional study. J Am ColI Surg 1997;84:596-604.

  22. Minton JP, Foecking MK, Webster OJ, Matthews RH. Caffeine, cyclic nucleotides, and breast disease. Surgery 1979;86:105-9.

  23. Minton JP, Abou-Issa H, Reiches N, Roseman JM. Clinical and biochemical studies on methylxanthine-related fibrocystic breast disease. Surgery 1981;90:299-304.

  24. Srivastava A, Mansel R, Arvind N, Prasad K, Dhar A, Chabra A. Evidence based management of mastalgia. Breast 2007;16:503-12.

  25. Marshall J, Graham S, Swanson M. Caffeine consumption and benign breast disease: a case-control comparison. Am J Public Health 1982;72:610-2.

  26. Schairer C, Brinton LA, Hoover RN. Methylxanthines and benign breast disease. Am J Epidemiol1986: 124: 603-11.

  27. Lubin F, Ron E, Wax y, Black M, Funaro M. Shitrit A. A case-control study of caffeine and methylxanthines in benign breast dlsease. JAMA 1985;253:2388-92.

  28. Lawson OH, Jick H, Rothman KJ. Coffee and tea consumption and breast disease. Surgery 1981;90:801-3.

  29. Odenheimer DJ, Zunzunequi MV, King MC, Shipler CP, Friedman GD. Risk factors for benign breast disease: a case-control study of discordant twins. Am J Epidemiol 1984;120:565-71.

  30. Boyle CA, Berkowitz GS, LiVolsi VA, Ort S, et al. Caffeine consumption and fibrocystic breast disease: a case-control epidemiologic study. J Natl Cancer Inst 1984;72:1015-9.

  31. La Vecchia C, Franceschi S, Parazzini F, Regallo M, et al. Benign breast disease and consumption of beverages containing methylxanthines. J Natl Cancer Inst 1985;74:995-1000.

  32. Ernster VL, Mason L, Goodson WH III, Sickles EA, et al. Effects of caffeine-free diet on benign breast disease: a randomized trial. Surgery 1982;91:263-7.

  33. London RS, Sundaram GS, Murphy L, Manimekalai S, et al. The effect of vitamin E on mammary dysplasia: a double-blind study. Obstet Gynecol 1985;65:104-6.

  34. Ernster VL, Goodson WH, Hunt TK, Petrakis NL, Sickles EA, Miike R. Vitamin E and benign breast “disease”: a double-blind, randomized clinical trial. Surgery 1985;97:490-4.

  35. Meyer EC, Sommers DK, Reitz CJ, Mentis H. Vitamin E and benign breast disease. Surgery 1990;107:549-51

  36. McFayden IJ, Forrest AP, Chetty U, Raab G. Cyclical breast pain-some observations and the difficulties in treatment. Br J Clin Pract 1992:46:161-4.

  37. Wetzig NR. Mastalgia: a 3 year Australian study. Aust N Z J Surg 1994;64:329-31.

  38. Smallwood J, Ah-kye D, Taylor I. Vitamin B6 in the treatment of pre-menstrual mastalgia. Br J Clin Pract 1986;40:532-3.

  39. Preece PE, Hanslip JI, Gilbert L, Walker O, et al. Evening primrose oil (efamol) for mastalgia. In: Horrobin DF, ed. Clinical uses of essential fatty acids. Montreal: Eden Press,1982;pp:147-54.

  40. Mansel RE, Pye JK, Hughes LE. Effects of essential fatty acids on cyclical mastalgia and noncyclical breast disorders. In: Horrobin DF, ed. Omega-6 essential fatty acids: pathophysiology and roles in clinical medicine. New York: Wiley-Liss, 1990;pp:557-67.

  41. Boyd NF, Shannon P, Kriukov V, Fish E, et al. Effect of a low-fat high-carbohydrate diet on symptoms of cyclical mastopathy. Lancet 1988; 2:128-32.

  42. Ingram DM, Hickling C, West L, Mahe LJ, Dunbar PM. A double-blind randomized controlled trial of isoflavones in the treatment of cyclical mastalgia. Breast 2002;11:170-4.

  43. Goss PE, Li T, Theriault M, Pinto S, Thompson L. Effects of dietary flaxseed in women with cyclical mastalgia. Breast Cancer Res Treta 2000;64:49.

  44. Staba EJ, Staba JE. Ginseng (Panex species). In: Chandler F, ed. Herbs: everyday reference for health professionals. Ottawa: Canadian Pharmacist Association and the Canadian Medical Association. 2000;pp:130-5.

  45. Halaska M, Raus K, Beles P, Martan A, Paithner KG. Treatment of cyclical mastodynia using an extract of Vitex agnus castus: results of a double-blind comparison with a placebo. Ceska Gynekol 1998;63:388-92.

  46. Nappi, C, Affinito P, DiCarlo C, Esposito G. Montemagno U. Double-blind controlled trial of progesterone vaginal cream treatment for cyclical mastodynia in women with benign breast disease. J Endocrinol lnvest 1992;15:801-6.

  47. Pierart J, Pierart C. Eficacia de la nimesulida en el tratamiento de la mastalgia. Rev Chil Cir 2003;55:326-34.

  48. Irving AD, Morrison SL. Effectiveness of topical non-steroidal anti-inflammatory drugs in the management of breast pain. J R ColI Surg Edinb 1998;43:158-9.

  49. Colak T, Ipek T, Kanik A, Ogetman Z, Aydin S. Efficacy of topical nonsteroidal drugs in mastalgia treatment. J Am Coll Surg 2003;196:525-30.

  50. O’Brien PMS, Abukhalil lEH. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol. Am J Obstet Gynecol 1999;180:18-23.

  51. Davies EL, Cochrane RA, Stansfield K, Sweetland HM, Mansel RE. Is there a role for surgery in the treatment of mastalgia? Breast 1999;8:285-8.

  52. Mansel RE, Dogliotti L. European multicentre trial of bromocriptine in cyclical mastalgia. Lancet 1990;335:190-3.

  53. Mansel RE, Hughes LE. Breast pain and nodularity. In: Hughes LE, Mantel RE, Webster DJT, eds. Benign disorders and diseases of the breast. Concepts and clinical management. 2nd ed. London: WB Saunders, 2000;pp:95-121.

  54. Davies EL, Gateley CA, Miers M, Mansel RE. The long-term course of mastalgia. JR Soc Med 1998;91:462-4

  55. Sutton GCJ, Palmer JO, Royce GT. Breast pain and the thoracic outlet compression syndrome. Breast 1993;2:250-2.




2020     |     www.medigraphic.com